Douglas C.A. Taylor

716 total citations
50 papers, 554 citations indexed

About

Douglas C.A. Taylor is a scholar working on Gastroenterology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Douglas C.A. Taylor has authored 50 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Gastroenterology, 21 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Douglas C.A. Taylor's work include Gastrointestinal motility and disorders (18 papers), Gastroesophageal reflux and treatments (10 papers) and Gastrointestinal Tumor Research and Treatment (8 papers). Douglas C.A. Taylor is often cited by papers focused on Gastrointestinal motility and disorders (18 papers), Gastroesophageal reflux and treatments (10 papers) and Gastrointestinal Tumor Research and Treatment (8 papers). Douglas C.A. Taylor collaborates with scholars based in United States, United Kingdom and Spain. Douglas C.A. Taylor's co-authors include Anju Parthan, Milton C. Weinstein, Vivek Pawar, John Coombs, Nicole Yurgin, Hema N. Viswanathan, Ankur Pandya, Denise Kruzikas, Paula Chu and Mason W. Russell and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Douglas C.A. Taylor

49 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas C.A. Taylor United States 14 195 133 122 105 91 50 554
Jessica X. Yu United States 11 241 1.2× 57 0.4× 83 0.7× 12 0.1× 83 0.9× 45 456
Kathleen Lang United States 16 63 0.3× 16 0.1× 155 1.3× 162 1.5× 246 2.7× 33 764
Goran Stanojević Serbia 11 135 0.7× 40 0.3× 45 0.4× 26 0.2× 112 1.2× 52 461
M. A. Tazi Morocco 14 267 1.4× 35 0.3× 361 3.0× 32 0.3× 499 5.5× 21 970
W. Clark United Kingdom 10 85 0.4× 80 0.6× 37 0.3× 107 1.0× 33 0.4× 15 741
Daniel Galandi Germany 10 202 1.0× 35 0.3× 99 0.8× 18 0.2× 71 0.8× 13 505
Michele L. Johnson United States 15 438 2.2× 149 1.1× 285 2.3× 37 0.4× 65 0.7× 48 737
Yasuhiro Hagiwara Japan 12 81 0.4× 8 0.1× 123 1.0× 50 0.5× 182 2.0× 51 455
Dainius Pavalkis Lithuania 17 409 2.1× 42 0.3× 97 0.8× 30 0.3× 329 3.6× 49 744
E. W. M. Grijseels Netherlands 12 103 0.5× 4 0.0× 133 1.1× 79 0.8× 13 0.1× 24 506

Countries citing papers authored by Douglas C.A. Taylor

Since Specialization
Citations

This map shows the geographic impact of Douglas C.A. Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas C.A. Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas C.A. Taylor more than expected).

Fields of papers citing papers by Douglas C.A. Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas C.A. Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas C.A. Taylor. The network helps show where Douglas C.A. Taylor may publish in the future.

Co-authorship network of co-authors of Douglas C.A. Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas C.A. Taylor. A scholar is included among the top collaborators of Douglas C.A. Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas C.A. Taylor. Douglas C.A. Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zullo, Andrew R., et al.. (2023). The Burden and Treatment of Chronic Constipation Among US Nursing Home Residents. Journal of the American Medical Directors Association. 24(8). 1247–1252.e5. 1 indexed citations
3.
Taylor, Douglas C.A., et al.. (2018). Health Care Resource Use and Costs Pre- and Post-Treatment Initiation With Linaclotide: Retrospective Analyses of a U.S. Insured Population.. PubMed. 27(2). 33–40. 2 indexed citations
4.
Taylor, Douglas C.A., et al.. (2016). Economic Evaluation of Linaclotide for the Treatment of Adult Patients With Chronic Idiopathic Constipation in the United States.. PubMed. 25(2). 41–8. 3 indexed citations
5.
Taylor, Douglas C.A., et al.. (2014). Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United States. Journal of Medical Economics. 18(4). 283–294. 10 indexed citations
6.
Parthan, Anju, et al.. (2013). Budgetary Impact Analysis of Denosumab in a US Health Plan. The American Journal of Managed Care. 5. 1 indexed citations
7.
8.
9.
Parthan, Anju, et al.. (2013). Comparison of Different Adjuvant Therapies for 9 Resectable Cancer Types. Postgraduate Medicine. 125(2). 83–91. 1 indexed citations
10.
Huang, Huanhuan, et al.. (2013). Cost-Effectiveness Of Linaclotide For The Treatment Of Adult Patients In The Us With Irritable Bowel Syndrome With Constipation. Value in Health. 16(3). A213–A213. 1 indexed citations
11.
Parthan, Anju, et al.. (2013). Cost Effectiveness of Denosumab versus Oral Bisphosphonates for Postmenopausal Osteoporosis in the US. Applied Health Economics and Health Policy. 11(5). 485–497. 66 indexed citations
12.
13.
Taylor, Douglas C.A., et al.. (2011). Epidemiology, survival, and costs of localized gastrointestinal stromal tumors. SHILAP Revista de lepidopterología. 7 indexed citations
14.
Taylor, Douglas C.A., et al.. (2011). Incorporating Calibrated Model Parameters into Sensitivity Analyses. PharmacoEconomics. 30(2). 119–126. 19 indexed citations
15.
Taylor, Douglas C.A., et al.. (2010). Methods of Model Calibration. PharmacoEconomics. 28(11). 995–1000. 24 indexed citations
16.
Taylor, Douglas C.A., et al.. (2010). Budgetary Impact of Treatment with Adjuvant Imatinib for 1 Year Following Surgical Resection of Kit-Positive Localized Gastrointestinal Stromal Tumors. Journal of Managed Care Pharmacy. 16(7). 482–491. 8 indexed citations
17.
Wagner, Monika, Mireille Goetghebeur, Elizabeth Merikle, et al.. (2009). Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada.. PubMed. 16(2). e331–45. 13 indexed citations
18.
Taylor, Douglas C.A., Paula Chu, Virginia M. Rosen, Christine L. Baker, & David Thompson. (2008). Budgetary Impact of Varenicline in Smoking Cessation in the United Kingdom. Value in Health. 12(1). 28–33. 11 indexed citations
19.
20.
Russell, Mason W., et al.. (2002). Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients.. PubMed. 8(1 Suppl). S3–9. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jessica X. Yu Breakdown of academic impact, for papers by Kathleen Lang Breakdown of academic impact, for papers by Goran Stanojević Breakdown of academic impact, for papers by M. A. Tazi Breakdown of academic impact, for papers by W. Clark Breakdown of academic impact, for papers by Daniel Galandi Breakdown of academic impact, for papers by Michele L. Johnson Breakdown of academic impact, for papers by Yasuhiro Hagiwara Breakdown of academic impact, for papers by Dainius Pavalkis Breakdown of academic impact, for papers by E. W. M. Grijseels
Rankless by CCL
2026